General Information
BounceWatch is an independent company data service, not affiliated with Akelos Inc. To contact Akelos Inc, visit akelosinc.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Akelos Inc compare?
A PDF of Akelos Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Akelos Inc soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Akelos Inc on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biopharma
About Akelos Inc
Business keywords: biopharmaceutical, neuropathic pain, opioid alternatives, drug development, pre-clinical, non-narcotic drugs, research collaboration, anti-hyperalgesic drug, chronic pain, innovative science, intellectual property, Columbia University, Weill Cornell Medicine, neuroscience research, clinical company
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $1.76M | 1 |
National Institutes of Health
|
22 Jan 2020 |
| Seed Round | $295.00K | - |
|
23 Oct 2018 |
Akelos Inc Alternatives & Competitors
View All AlternativesInnovative solutions for visceral hypersensitivity and pancreatitis through pioneering therapeutic d...
Non-opioid drugs for chronic pain to attack a global health epidemic.
Advancing the Science of Well-Being.
FAQ About Akelos Inc
Source: BounceWatch company record for Akelos Inc, https://bouncewatch.com/company/akelos-inc, updated 14 September 2024. When citing, please name BounceWatch and link this page.